A few Indian studies on the PD-L1 research in NSCLC by Kumar et al., Domadia et al., and Vallonthaiel et al. have reported positivity rates of 33.66% (34/101), 47% (63/134), and 27% (24/89) [15,19-22]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.